A Case of Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

A Case of Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma

Published:2022 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Imakura Takeshi¹,Sato Seidai¹,Tomonari Tetsu²,Murakami Kojin¹,Takahashi Naoki¹,Naito Nobuhito¹,Mima Masato¹,Kagawa Kozo¹,Koyama Kazuya¹,Nishimura Haruka¹,Kawano Hiroshi¹,Nokihara Hiroshi¹,Azuma Masahiko¹,Takayama Tetsuji²,Nishioka Yasuhiko¹

Affiliation:

1. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Japan

2. Department of Gastroenterology and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7300-21/_pdf

Reference18 articles.

1. 1. Matsui J, Yamamoto Y, Funahashi Y, et al. E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition. Int J Cancer 122: 664-671, 2008.

2. 2. Matsui J, Funahashi Y, Uenaka T, et al. Multikinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB- 231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res 14: 5459-5465, 2008.